-

Mirion Technologies Signs Agreement with TerraPower for Molten Chloride Reactor Experiment

Contract to provide Nuclear Instrumentation System Design and Fabrication that will Advance the World’s First Critical Fast-Spectrum Salt Reactor

ATLANTA--(BUSINESS WIRE)--Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced an agreement with nuclear innovation company TerraPower to design and fabricate key components of their Molten Chloride Reactor Experiment (MCRE), the world’s first critical fast-spectrum salt reactor. This collaboration reinforces TerraPower and Mirion’s commitment to fostering sustainable, low-carbon energy solutions that address climate change and support a net-zero future.

In February 2023, TerraPower and Southern Company announced their agreement to design, construct and operate the MCRE at Idaho National Laboratory as part of the U.S. Department of Energy’s Advanced Reactor Demonstration Program (ARDP), which aims to speed the growth of safe and affordable advanced reactor technologies for a carbon-free economy. The MCRE will inform the design, licensing and operation of TerraPower’s Molten Chloride Fast Reactor (MCFR) – an innovative reactor technology that could provide low-cost, clean energy at scale.

Mirion will supply a custom-built MCRE Nuclear Instrumentation System (NIS), a critical safety-significant component that will help protect the reactor’s core from overpower and continuously monitor the neutronic condition of the core.

“Throughout the process of bringing the Molten Chloride Fast Reactor to market, we have found that working with a diverse supply chain strengthens our ability to deliver a cutting-edge technology,” said Jeff Latkowski, Senior Vice President for the Molten Chloride Fast Reactor. “Through the MCRE Risk Reduction Program and in partnership with experts from various industries, we look forward to collaborating with these suppliers to advance nuclear technology.”

A market leader in nuclear power solutions including radiation monitoring systems, reactor instrumentation and controls, and criticality systems, Mirion has been actively engaged in supporting the development of the next generation of reactor technologies. The partnership with TerraPower on the MCRE is in line with the company’s mission to use its extensive knowledge of ionizing radiation to benefit humanity.

“We are proud to be partnering with TerraPower on this groundbreaking technology aimed at bolstering sustainable and accessible energy as part of a net-zero future,” said Silas Stark, Vice President, Americas, Radiation Monitoring Systems at Mirion. “We look forward to applying our deep experience and understanding of nuclear technology to support the success of the MCRE project.”

View Mirion products and solutions at mirion.com/smr.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,700 people and operates in 12 countries. Learn more at mirion.com.

About TerraPower

TerraPower is a leading nuclear innovation company that strives to improve the world through nuclear energy and science. Since it was founded by Bill Gates and a group of like-minded visionaries, TerraPower has emerged as an incubator and developer of ideas and technologies that offer energy independence, environmental sustainability, medical advancement, and other cutting-edge opportunities. It accepts and tackles some of the world’s most difficult challenges. Behind each of its innovations and programs, TerraPower actively works to bring together the strengths and experiences of the world’s public and private sectors to answer pressing global needs. Learn more at terrapower.com.

Contacts

For investor inquiries:
Jerry Estes
ir@mirion.com

For media inquiries:
Mirion
Erin Schesny
media@mirion.com

TerraPower
press@terrapower.com

Mirion Technologies

NYSE:MIR

Release Versions

Contacts

For investor inquiries:
Jerry Estes
ir@mirion.com

For media inquiries:
Mirion
Erin Schesny
media@mirion.com

TerraPower
press@terrapower.com

More News From Mirion Technologies

Mirion Announces Second Quarter 2024 Financial Results and Updates Full Year Guidance

ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the second quarter ended June 30, 2024. “Our second quarter results were in-line with our expectations,” stated Thomas Logan, Mirion’s Chief Executive Officer. “Both segments delivered steady top-line growth and strong Adjusted EBITDA margin expansion...

Mirion Announces Earnings Release and Conference Call Date for Second Quarter 2024

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for second quarter 2024 after market close on Thursday, August 1, 2024. Following the news release, the company will host a conference call the next day, Friday, August 2, 2024, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be availabl...

Mirion Announces Updated Time of Presentation at Jefferies’ 2024 Global Healthcare Conference

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that its management team’s presentation at Jefferies’ 2024 Global Healthcare Conference will now begin at 3:30 PM ET on Thursday, June 6, 2024. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of the webcast will be available at the same location within twelve hours of the conclusion of the event. About Mirion Mirion (NYSE...
Back to Newsroom